Dual Targeting of Toll-Like Receptor 4 and Angiotensin-Converting Enzyme 2: A proposed Approach to SARS-CoV-2 Treatment
Laura Kate Gadanec, Tawar Qaradakhi, Kristen Renee McSweeney, Benazir Ashiana Ali, Anthony Zulli, Vasso Apostolopoulos
Abstract
Keywords:: ACE2angiotensin-converting enzyme 2coronaviruscoronavirus disease 2019COVID-19SARS-CoV-2TLR4Toll-like receptor
Topics & Concepts
Angiotensin-converting enzyme 2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ReceptorVirologyCoronavirus disease 2019 (COVID-19)Toll-like receptorEnzyme2019-20 coronavirus outbreakDual (grammatical number)TollPharmacologyChemistryMedicineBiologyImmunologyBiochemistryInternal medicineInnate immune systemInfectious disease (medical specialty)DiseaseLiteratureArtOutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCancer, Stress, Anesthesia, and Immune Response